Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · IEX Real-Time Price · USD
16.00
+0.28 (1.78%)
Apr 29, 2024, 4:30 PM EDT - Market closed
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $402.09 million as of April 29, 2024.
Market Cap
402.09M
Enterprise Value
277.47M
1-Year Change
n/a
Ranking
Category
Stock Price
$16.00
Market Cap Chart
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 26, 2024 | 425.30M | -1.69% |
| Apr 25, 2024 | 432.60M | 0.37% |
| Apr 24, 2024 | 431.00M | 0.12% |
| Apr 23, 2024 | 430.50M | 1.08% |
| Apr 22, 2024 | 425.90M | 2.09% |
| Apr 19, 2024 | 417.20M | -0.38% |
| Apr 18, 2024 | 418.80M | 0.58% |
| Apr 17, 2024 | 416.40M | -1.02% |
| Apr 16, 2024 | 420.70M | 6.43% |
| Apr 15, 2024 | 395.30M | -5.75% |
| Apr 12, 2024 | 419.40M | -2.62% |
| Apr 11, 2024 | 430.70M | 7.92% |
| Apr 10, 2024 | 399.10M | -3.01% |
| Apr 9, 2024 | 411.50M | -0.27% |
| Apr 8, 2024 | 412.60M | 2.61% |
| Apr 5, 2024 | 402.09M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 414.64M |
| Acelyrin | 412.72M |
| biote | 408.43M |
| Lexeo Therapeutics | 405.26M |
| Replimune Group | 403.93M |
| Pulse Biosciences | 400.38M |
| Adaptive Biotechnologies | 399.00M |
| OraSure Technologies | 398.50M |